Please edit posts and set "Sticky Posts" for this section.

Okay, I'm doing now | How To (method 1) | (method 2)

TAGRISSO Reduced the Risk of Disease Recurrence in the Brain by 82% in the Adjuvant Treatment of Early-Stage EGFR-Mutated Lung Cancer

Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Distant Metastasis or Death by 40% Versus Placebo as Adjuvant Treatment in Resected, High-Risk Stage III Melanoma

Resumen: BeiGene presenta datos en el ESMO Virtual Congress 2020 sobre el ensayo de fase 3 de tislelizumab en el tratamiento de primera línea del cáncer de pulmón de células no pequeñas y no escamosas y el ensayo de fase 2 de pamiparib…

Takeda präsentiert neue Daten zu wissenschaftlichen Fortschritten bei Lungenkrebs auf dem virtuellen ESMO-Kongress

ESMO: Merck and AstraZeneca’s 5-Year Lynparza Data in Ovarian Cancer and More

Incyte annonce les résultats encourageants de l'essai de Phase 2 sur le retifanlimab (INCMGA0012) chez des patients atteints d'un carcinome épidermoïde avancé du canal anal déjà traités

Biotechnology Reagents Market – Roadmap for Recovery from COVID-19 | Presence of High-throughput to Boost the Market Growth | Technavio

Samenvatting: Incyte kondigt bemoedigende resultaten aan van fase 2-onderzoek met Retifanlimab (INCMGA0012) bij patiënten met eerder behandeld, gevorderd squamous cell carcinoma of the anal canal

Takeda apresenta novos dados no congresso virtual da ESMO que destacam os avanços científicos no tratamento do câncer de pulmão

Roche Launches New COVID-19 Antibody Test to Support Vaccine Testing